News & Media
Hind Bouzid, PhD, discusses recent findings from the Jaiswal lab on an association between clonal hematopoiesis of indeterminate potential and Alzheimer’s Disease, as well as future directions for this research.
The Jaiswal lab at Stanford University, Stanford, CA, has lots of exciting ongoing research, focusing on somatic mutations and how they contribute to the development of cancer and other age-associated diseases. Here, Siddhartha Jaiswal, MD, PhD, discusses some of this work, and gives us an update on an upcoming paper. This interview took place at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.
PLMI President Dr. Jeffrey Bland is very excited about this year's Thought Leaders Consortium and he is making time to share his thoughts about each speaker on the program. In this video he discusses Siddhartha Jaiswal, PhD, MD who is a recent faculty recruit to Stanford School of Medicine. (2018)
Clonal hematopoiesis of indeterminate potential (or CHIP) increases mortality and coronary heart disease. Could CHIP also cause atherosclerosis? New research findings are summarized in a short video. (2017)
Related News
“Are you at risk of leukaemia? Scientists identify mutation that can predict if a person will develop blood cancer within five years” (2014)
“Harvard Scientists Find New Way to Predict Risk of Blood Cancer Long Before It Strikes” (2014)
“Atherosclerosis: Somatic mutations in haematopoietic cells contribute to atherosclerosis” (nature Reviews Cardiology 2017)
“Cardiovascular Disease Risk Is Increased by Aging-Related Mutations in Blood Cells” (2017)